Chuanxu Liu

1.1k total citations
30 papers, 776 citations indexed

About

Chuanxu Liu is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Chuanxu Liu has authored 30 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Chuanxu Liu's work include Retinoids in leukemia and cellular processes (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (5 papers). Chuanxu Liu is often cited by papers focused on Retinoids in leukemia and cellular processes (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (5 papers). Chuanxu Liu collaborates with scholars based in China, United States and Thailand. Chuanxu Liu's co-authors include Yingli Wu, Guoqiang Chen, Meng Zhao, Ruifeng Zhang, Huanying Wan, Lin Zhou, Shao-Ming Shen, Shihua Liao, Kun Yang and Qing Yun Li and has published in prestigious journals such as Blood, The Journal of Immunology and Chemical Communications.

In The Last Decade

Chuanxu Liu

29 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanxu Liu China 12 470 112 96 84 83 30 776
Takanari Nakano Japan 21 412 0.9× 92 0.8× 116 1.2× 69 0.8× 28 0.3× 57 1.1k
Tamás Csonka Hungary 9 525 1.1× 71 0.6× 68 0.7× 207 2.5× 27 0.3× 22 793
Hiroaki Uranishi Japan 14 671 1.4× 184 1.6× 145 1.5× 273 3.3× 61 0.7× 24 1.1k
Mei Zhang China 17 334 0.7× 143 1.3× 140 1.5× 133 1.6× 42 0.5× 54 842
Jiagao Lv China 17 393 0.8× 96 0.9× 105 1.1× 101 1.2× 47 0.6× 40 1.0k
Allison Gartung United States 13 281 0.6× 112 1.0× 133 1.4× 84 1.0× 85 1.0× 20 751
Xiaojia Guo United States 17 495 1.1× 81 0.7× 113 1.2× 82 1.0× 69 0.8× 42 859
Liang Han China 15 246 0.5× 76 0.7× 119 1.2× 105 1.3× 55 0.7× 44 716
Chris Black United States 12 396 0.8× 77 0.7× 48 0.5× 110 1.3× 23 0.3× 13 954
Ken Karasawa Japan 18 413 0.9× 87 0.8× 119 1.2× 47 0.6× 12 0.1× 49 947

Countries citing papers authored by Chuanxu Liu

Since Specialization
Citations

This map shows the geographic impact of Chuanxu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanxu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanxu Liu more than expected).

Fields of papers citing papers by Chuanxu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanxu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanxu Liu. The network helps show where Chuanxu Liu may publish in the future.

Co-authorship network of co-authors of Chuanxu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanxu Liu. A scholar is included among the top collaborators of Chuanxu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanxu Liu. Chuanxu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Defeng, Chuanxu Liu, Yuhuan Liu, et al.. (2025). Discovery of novel and highly potent anticancer agents enabled by selenium scanning of noscapine. European Journal of Medicinal Chemistry. 293. 117714–117714.
2.
Tao, Rong, Chuanxu Liu, Wenhao Zhang, Yang Zhu, & Yujie Ma. (2023). Anti-PD-1 Antibody Sintilimab in Combination with Anlotinib and Pegaspargase As a Highly Effective Salvage Regimen for the Treatment of Relapsed or Refractory Natural Killer /T-Cell Lymphoma. Blood. 142(Supplement 1). 1694–1694. 1 indexed citations
3.
Xu, Chao, et al.. (2023). DBE-Net: Dual Boundary-Guided Attention Exploration Network for Polyp Segmentation. Diagnostics. 13(5). 896–896. 3 indexed citations
4.
Liu, Chuanxu, Xinyu Ding, Gaoyang Li, et al.. (2023). Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma. iScience. 26(8). 107369–107369. 3 indexed citations
5.
Tao, Rong, Chuanxu Liu, Wenhao Zhang, et al.. (2023). Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. The Oncologist. 29(1). e90–e96. 5 indexed citations
6.
Ma, Chunmin, Meng Liu, Jiong Zhang, et al.. (2021). ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway. Chemico-Biological Interactions. 351. 109770–109770. 3 indexed citations
7.
Zhang, Youping, Ting Luo, Xinyu Ding, et al.. (2021). Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia. Biochemical and Biophysical Research Communications. 547. 162–168. 11 indexed citations
8.
Wan, Yi, Pan Peng, Wenbin Cai, et al.. (2019). A cascade approach to 3D cyclic carbamates via an ionic decarboxylative functionalization of olefinic oxamic acids. Chemical Communications. 56(1). 86–89. 11 indexed citations
9.
10.
Luo, Hao, Bo Jing, Yu Xia, et al.. (2019). WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell International. 19(1). 56–56. 26 indexed citations
11.
Wan, Jiangbo, Fang Huang, Siguo Hao, et al.. (2017). Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation. Cellular Physiology and Biochemistry. 43(1). 353–366. 11 indexed citations
12.
Wei, Wei, Chuanxu Liu, Lili Song, et al.. (2016). Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells. Molecular Medicine Reports. 13(3). 2201–2207. 5 indexed citations
13.
Zhao, Shan, Chunmin Ma, Chuanxu Liu, et al.. (2012). Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells. International Journal of Molecular Medicine. 30(4). 939–944. 40 indexed citations
14.
Liu, Chuanxu, Huchen Zhou, Qianqian Yin, Yingli Wu, & Guoqiang Chen. (2012). Targeting peroxiredoxins against leukemia. Experimental Cell Research. 319(2). 170–176. 23 indexed citations
15.
Liu, Chuanxu, Qianqian Yin, Huchen Zhou, et al.. (2012). Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. Nature Chemical Biology. 8(5). 486–493. 180 indexed citations
16.
Yang, Zhongyin, Ying Qu, Qing Zhang, et al.. (2011). Knockdown of metallopanstimulin‐1 inhibits NF‐κB signaling at different levels: The role of apoptosis induction of gastric cancer cells. International Journal of Cancer. 130(12). 2761–2770. 30 indexed citations
17.
He, Licai, Hanzhang Xu, Zhimin Gu, et al.. (2011). Ikaros is degraded by proteasome-dependent mechanism in the early phase of apoptosis induction. Biochemical and Biophysical Research Communications. 406(3). 430–434. 10 indexed citations
18.
Gao, Feng‐Hou, Yingli Wu, Meng Zhao, et al.. (2009). Protein Kinase C-δ mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. Experimental Cell Research. 315(19). 3250–3258. 32 indexed citations
19.
Wang, Xiaodong, Chuanxu Liu, Yingli Wu, & Jing Chen. (2009). [Hypoxia and its simulant CoCl(2) down-regulates Foxp3 expression independent from HIF-1alpha].. PubMed. 17(3). 533–6. 1 indexed citations
20.
Chen, Chi‐An, Chuanxu Liu, Hsiu‐Chuan Chou, et al.. (2006). The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. International Journal of Gynecological Cancer. 16(5). 1801–1808. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanari Nakano Breakdown of academic impact, for papers by Tamás Csonka Breakdown of academic impact, for papers by Hiroaki Uranishi Breakdown of academic impact, for papers by Mei Zhang Breakdown of academic impact, for papers by Jiagao Lv Breakdown of academic impact, for papers by Allison Gartung Breakdown of academic impact, for papers by Xiaojia Guo Breakdown of academic impact, for papers by Liang Han Breakdown of academic impact, for papers by Chris Black Breakdown of academic impact, for papers by Ken Karasawa
Rankless by CCL
2026